Bacterio@P3Cell

Équipe bactériologie @inserm @universitereims @ChudeReims Innovation résistance aux antibiotiques et virulence vis-à-vis de l’épithélium respiratoire

[David R. Liu @davidrliu]

Today we report in @natBME the systematic application of six recent prime editing developments to enable efficient and functional correction of CFTR F508del, the predominant mutation that causes cystic fibrosis (CF), in primary airway cells from CF patients.
https://t.co/Nw2xycAZMS
(1/6)

[PLOS Pathogens @PLOSPathogens]

We're excited to introduce a revised scope for @PLOSPathogens! Read the scope updates, see details on how we've broadened our article formats for submission, and more in our latest Editorial: https://t.co/iYuH0EhgnH.

[Eric Déziel @DezielEric]

New preprint from the lab! @d_oliveirathays noticed that activity of the Pseudomonas aeruginosa quorum sensing regulator RhlR is higher at 25°C than at 37°C, and found indications that such a lower temperature promotes its affinity for its C4-HSL ligand https://t.co/cUMecuU7NE

[Bacterio@P3Cell @P3cellGuillard]

FilmArray Pneumonia Plus @BioFireDX doesn't detect 2 K. aerogenes subspecies. Our paper from @InsermEst UMRS-1250 @P3cellGuillard @universitereims and @CHUdeReims is published in @CMIJournal.
All you want to know 👉https://t.co/RZuxPvCWN4

[FSMR - RespiFIL 🫁 @RespiFIL]

🔴 #J2R 2023 @SPLF_SocPneumo✨

Coup d'envoi des journées de #recherche 🔬respiratoire 🫁 au palais des Congrès de @villedetours !
Un concentré de chercheurs qui partagent leur innovation et découverte 💡 dans les #maladiesrespiratoires
Merci 🙏 @GroupeJ2r
#maladiesrares

[Loic Guillot @LG_LoicGuillot]

Happy to share our new study @JournalofCF 🦠#pseudomonas
Airway infections as a risk factor for Pseudomonas aeruginosa acquisit... https://t.co/O5CQWAGBX5 @crsa_paris @FRM_officiel @vaincrelamuco @HarrietCorvol @Julie_Mesinele @MedecineSU @InsermIDF

[Bacterio@P3Cell @P3cellGuillard]

Maybe Acinetobacter baumannii?

[ASM @ASMicrobiology]

In #mSystems: Mutation in the 2-component regulator BaeSR mediates Acinetobacter baumanii resistance to cefiderocol, a novel siderophore-conjugated cephalosporin. The results may be useful for developing ways to delay bacterial resistance to the drug. https://t.co/MCrAPWqUtE

[Lionel Case @lionel_case]

👋 THREAD
Rédiger une demande de financement en recherche biomédicale 💊🧪
Je vois passer des dossiers qui se tirent une balle dans le pied et ça me fait de la peine.
Voici quelques conseils.
Amicaux.
1/11

[Bacterio@P3Cell @P3cellGuillard]

Très intéressant. A lire…et à méditer.

[Caroline Goujon, PhD @caro_goujon]

Recherche : un rapport du CNRS dénonce les entraves administratives – via @lemondefr https://t.co/CXLalQD9gO

[Bacterio@P3Cell @P3cellGuillard]

@FillouxLab @SCELSE_SG Quel objectif! Admiratif. Allez!!! 🏃‍♂️au début et 🏎️ à la fin. 👏

[Société de Pneumologie de Langue Française (SPLF) @SPLF_SocPneumo]

Mission #ATS2023
#Infectiologie #readaptation #respiratoire
Dégradation de la fonction respiratoire après une infection à VRS
👉https://t.co/RlB2nOC9au
Réadaptation respiratoire post-exacerbation de BPCO
👉https://t.co/k36GEZv3aL
@PneumoCphg @ajpo2 @CEPR_Inf_Immun @GroupeJ2r

[Alan R. Hauser @AlanRHauser1]

Pls RT: Open postdoc position with @AlanRHauser1 Lab (Northwestern U, Chicago) studying pathogenesis/antibiotic resistance of Pseudomonas and Klebsiella. How do these nasty bugs cause infections and resist treatment? See https://t.co/qCmq3lgOin to apply.

[Bacterio@P3Cell @P3cellGuillard]

Great meeting for the #EURESTOP @COSTprogramme #CA21145. Plenty of 🇪🇺scientists here to tackle #AMR.

[Bacterio@P3Cell @P3cellGuillard]

Promising WG

[Smani Lab مختبر سمعاني @smani_lab]

Delighted to be able to participate in the upcoming #EURESTOP WG meeting in Brussels and present the WG2 update and meet our colleagues from the COST Action #CA21145 @CABD_UPO_CSIC @COSTprogramme

[Bacterio@P3Cell @P3cellGuillard]

Tout est dit…

[Matthieu Beauval @mattbeauv]

Mes collègues de travail sont toujours bien habillés.

[Bacterio@P3Cell @P3cellGuillard]

3/ Histology would have been interesting. ⁉️Bacterial load lower than with beads. 🧐
4/Are Biozzi mice more prompt to synthetize Ab?

[Bacterio@P3Cell @P3cellGuillard]

Sure, interesting model.
1/Intratracheal catheter can be used rather than surgery to deliver beads.
2/Dead mice after #staphylococcus and prior to #pseudomonas should be considered for the #3R rules.

[Geneviève HéryArnaud @Genevieve_Hery]

Finally, relevant models of #Pseudomonas aeruginosa chronic lung infection that don't use agar beads (a very poor model for mimicking chronic infection in my opinion).
Really interesting article (preprint).
🫁🧫🦠 #cysticfibrosis
https://t.co/caI1SfcrqA

[Bacterio@P3Cell @P3cellGuillard]

Few month ago, I’ve joined @PLOSPathogens Board of Editors as an Academic Editor. Very proud to be part of it. Glad to participate in peer-reviewing for an open science.

#pseudomonas #epithelium
@Inserm @InsermEst @universitereims @CHUdeReims

[Filloux lab @FillouxLab]

Excited to share our latest article published in @plospathogens: https://t.co/0Y3X5Pq0sT #plospathogensauthor

[Bacterio@P3Cell @P3cellGuillard]

You are looking for a PhD position. You are interested in #Pseudomonas aeruginosa and #respiratory epithelium. @universitereims our team @Inserm UMR-S 1250 offers a fully funded 3-year PhD position. For more details 👇. Please don't hesitate to contact us.